Intravenous Immunoglobulins for Prevention of BKV Infection in Kidney Transplant Recipients According to BKV Genotype-specific Neutralizing Antibody Titers at the Day of Transplantation.

NCT04222023 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

359

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplantation

Interventions

DRUG: Intravenous immunoglobulins (IVIG)

Sponsor

University Hospital, Strasbourg, France